Stay updated with breaking news from Pharmacodynamic Modeling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination with palbociclib -- NEW HAVEN, Conn. and NEW YORK, Nov. 28, 2023 --...
BOS-580 treatment improved markers of glycemic control and reduced liver steatosis across diabetic sub-populations with phenotypic NASHAdditional data support the continued development of BOS-580 once-monthly dosingCAMBRIDGE, Mass.--(BUSINESS WIRE)--Boston Pharmaceuticals, a clinical-stage biopharmaceutical company...
The June edition of SLAS Discovery features the cover article, 'A Perspective on Synthetic Biology in Drug Discovery and Development -- Current Impact and Future Opportunities' by Florian David, Ph.D. (Chalmers University of Technology, Gothenburg, Sweden), Andrew M. Davis, Ph.D. (AstraZeneca, Cambridge, England, UK). Michael Gossing, Ph.D., Martin A. Hayes, Ph.D., and Elvira Romero, Ph.D., and Louis H. Scott, Ph.D. (AstraZeneca, Gothenburg, Sweden), and Mark J. Wigglesworth, Ph.D. (AstraZeneca, London, England, UK).